Abbott quarterly profit beats as COVID-19 tests cushion virus impact

Abbott reported a better-than-anticipated quarterly profit as a surge in sales of its coronavirus tests helped it cushion a fall in demand for its devices due to virus-induced lockdowns and deferred elective care